← Evidence map

ArticleTexas Heart Institute journal2011

Rosuvastatin therapy does not affect serum MMP-13 or TIMP-1 levels in hypercholesterolemic patients.

Cihan Cevik et al.PubMed ↗Full text ↗

No numbers read from the abstract.

3 papers cite it

2011

2012

2013

2014

2015

2016

2017

2018

this papercites it

Rosuvastatin therapy does not affect serum MMP-13 or TIMP-1 levels in hypercholesterolemic patients. | OpenQuestion